PaceMate®

More than 1 million patients in the U.S. are hospitalized for heart failure every year. Cardiac device data can flag decompensation before it leads to a hospital stay. PaceMate® helps clinics coordinate around that data so they can act sooner. Stop by Booth #907 at Heart Failure Society of America 2026 in Phoenix this week. #HFSA2026 #HeartFailure #EPeeps

As AI becomes more involved in data review, prioritization, and workflow management, one question becomes increasingly important: Where should automation end and clinical judgment begin? Chief Medical Officer Dr. Benjamin Steinberg, Chief Product Officer Sean Shoffstall, and Chief Technology Officer Gabe Rosu will examine how organizations can gain efficiency while preserving clinical accountability and human oversight. This interactive discussion will be driven by audience questions and open conversation, with no slide presentation, just a candid exchange of ideas and real-world perspectives. Join us live on November 5th: https://bit.ly/3SVfIRK #PatientSafety #ClinicalAI #CardiacMonitoring #ResponsibleAI

Congratulations to Dr. Hidehiro Iwakawa, Dr. Prashanthan Sanders, and the full author team on their new publication in Heart Rhythm Society: "Leadless pacemaker, right ventricular pacing burden, and heart failure." Guidelines have long used 20% and 40% right ventricular pacing (RVP) thresholds for transvenous pacemakers, but it hasn't been clear whether they apply to leadless pacemakers. Using real-world remote monitoring data from PaceMate® (3,167 leadless pacemaker patients across 71 centers in 31 states and more than 45,000 transmissions), the team found: Baseline RVP of 20% or higher, and of 40% or higher, identified patients at increased risk of a heart failure diagnosis. Heart failure risk rose steadily as pacing burden increased, about 3.5% for every 10% increase in RVP, with no single safe cutoff. 38% of patients saw their pacing burden change by 10% or more over follow-up, which shows the value of tracking it continuously rather than only at implant. Current leadless systems don't have established upgrade pathways, so these findings point to the importance of careful patient selection and close follow-up for patients expected to need a high degree of ventricular pacing. We're grateful to partner with the Centre for Heart Rhythm Disorders at Adelaide University and Royal Adelaide Hospital, and with this outstanding group of investigators from across the U.S. It's a privilege to see PaceMate data support research that shapes how clinicians care for device patients. Congratulations to the full team: Hidehiro Iwakawa Prashanthan Sanders Melissa Middeldorp Saikiran Kakarla Mohanaraj Jayakumar Shaun Evans Alexis Puvrez Suneet Mittal Thomas Deering Andrea Russo James Freeman Anne Kroman Gene Fu Tina Baykaner Benjamin Donovan Robin Leahy Benjamin Steinberg Jonathan Ariyaratnam Read the full open-access study: https://lnkd.in/esy7mjb9 #HeartRhythm #Electrophysiology #LeadlessPacemaker #RemoteMonitoring #HeartFailure #PaceMate

Cardiac remote monitoring has evolved far beyond reviewing transmissions one by one. As monitoring volumes grow across pacemakers, ICDs, ILRs, and heart failure devices, device clinics need a new operational model. In this conversation, Dr. Satish Misra of Atrium Health explains why the future of remote monitoring is proactive population management, not reactive alert review. His framework for prioritizing alerts comes down to three questions: • What is the clinical impact? • How time-sensitive is it? • Which patient population is at risk? Watch the full discussion below. #CardiacRemoteMonitoring #DeviceClinic #Electrophysiology #RemoteMonitoring

Excited to see SSM Health in Shawnee, Oklahoma officially live with PaceMate® full-service cardiac remote monitoring. Congratulations to both teams on this milestone, and thank you for the collaboration throughout the implementation process. We're honored to help support your device clinic and the important work you do for patients every day. #CardiacRemoteMonitoring #DeviceClinic #EPeeps

Growing patient volumes. Increasing data. Persistent staffing constraints. Can AI help device clinics scale without compromising quality of care? That is one of the critical questions Chief Product Officer Sean Shoffstall, Chief Medical Officer Dr. Benjamin Steinberg, and Chief Technology Officer Gabe Rosu will address during our November 5th LinkedIn Live roundtable. Join the conversation to explore where AI can reduce administrative burden, improve data prioritization, and support more efficient clinical workflows. Follow the LinkedIn Live event to join the discussion: https://bit.ly/3SVfIRK #RemoteMonitoring #Electrophysiology #ClinicalWorkflow #HealthcareAI

As AFib Awareness Month comes to a close, we're focused on what comes after detection. Understanding a patient's atrial fibrillation burden is only the start. PaceMate® trends that burden in one place and correlates it with medications and outcomes, giving physicians a clearer path from data to treatment. Ryan Barone, SVP of Sales and Marketing, and Curt Harper, Sr. Director IDN Sales & Solution Architecture discuss how bringing AFib data out of the EHR and into a single, digestible view can help clinicians make more informed decisions. "All this data locked in Epic, locked in Cerner. Now we've brought that to the forefront." – Curt Harper Watch the full conversation below. #AFibAwarenessMonth #AtrialFibrillation #CardiacRemoteMonitoring

We are honored to be featured in the "Cool Tools in Clinic" workshop at Hearts in Sonoma and grateful for the opportunity to see PaceMate through the eyes of our customers.   Thank you to Robin Fischer, DNP, FNP-C, CHFN, Nurse Manager at UCSF Advanced Heart Failure Comprehensive Care Center and the UCSF Health team for sharing how they use PaceMate to support heart failure patients and streamline clinical workflows.   #HeartFailure #CardiacRemoteMonitoring #CustomerSymposium

Congratulations to the Medical University of South Carolina on a successful Cardiac Device Team Summit. PaceMate was proud to help support the event and host a lunch-and-learn session featuring Jason Hale, Co-Founder of PaceMate and Senior VP of Commercial Excellence, who presented on alert management. Thank you to the MUSC cardiac device team for the important work you do every day to advance patient care. We're honored to be your partner. #CardiacDeviceCare #DeviceClinic #CardiacRemoteMonitoring #Electrophysiology #MUSCHealth Hannah King

A vendor ranking should never be the basis for a comprehensive technology decision. Yet today, healthcare leaders are increasingly confronted with online comparison articles, scorecards, and "top platform" rankings that often lack transparent methodology, independent validation, or clinical evidence. The question isn't who ranks highest. The question is: Can the claims be proven? When evaluating a cardiac remote monitoring platform, administrators, IT leaders, physicians, and device clinics should expect evidence, published outcomes, security credentials, integration depth, and transparent performance data. That's why we developed a practical framework to help healthcare leaders separate marketing from measurable results. Five questions. One smarter evaluation process. Read the guide: https://bit.ly/3SGE3um #HealthcareLeadership #HealthcareTechnology #Cardiology #HealthcareInnovation #DigitalHealth #RemotePatientMonitoring #HealthSystems #CardiacMonitoring #HealthcareAdministratio